FDA Approves New Drug for Locally Advanced Skin Cancer (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD
Sonidegib (brand name: Odomzo) has been approved for the treatment of locally advanced basal cell carcinoma. It is indicated for adults …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Primary Care | Skin | Skin Cancer